First Time Loading...

Carna Biosciences Inc
TSE:4572

Watchlist Manager
Carna Biosciences Inc Logo
Carna Biosciences Inc
TSE:4572
Watchlist
Price: 441 JPY 6.01% Market Closed
Updated: May 9, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

4.3B
+4%
Assets
Growth Rates:
1 Year
+2%
3 Years
-10%
5 Years
+146%
7 Years
+70%
10 Years
+130%
472.4m
+26%
Liabilities
Growth Rates:
1 Year
-24%
3 Years
-53%
5 Years
-46%
7 Years
-43%
10 Years
+62%
3.9B
+2%
Equity
Growth Rates:
1 Year
+6%
3 Years
+1%
5 Years
+337%
7 Years
+123%
10 Years
+143%

Balance Sheet Decomposition
Carna Biosciences Inc

4.3B
Assets
472.4m
Liabilities
4.3B
Assets
472.4m
Liabilities
Current Assets 4.2B
Cash & Short-Term Investments 2.9B
Receivables 788.2m
Other Current Assets 514.2m
Non-Current Assets 158.4m
PP&E 105.5m
Intangibles 1.1m
Other Non-Current Assets 51.8m
Current Liabilities 375.9m
Accounts Payable 1.2m
Other Current Liabilities 374.7m
Non-Current Liabilities 96.4m
Long-Term Debt 56.4m
Other Non-Current Liabilities 40m

Balance Sheet
Carna Biosciences Inc

Rotate your device to view
Balance Sheet
Currency: JPY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
627
1 625
2 161
1 856
1 355
4 915
4 299
3 818
3 379
2 889
Cash Equivalents
627
1 625
2 161
1 856
1 355
4 915
4 299
3 818
3 379
2 889
Total Receivables
95
192
123
92
88
117
129
1 244
182
788
Accounts Receivables
95
192
123
92
88
117
129
1 244
182
788
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
119
125
122
118
111
99
105
110
119
140
Other Current Assets
66
54
87
68
118
143
175
146
424
374
Total Current Assets
908
1 996
2 493
2 134
1 672
5 275
4 708
5 318
4 104
4 191
PP&E Net
53
37
35
20
19
30
53
52
100
105
Intangible Assets
2
1
1
0
0
0
4
3
2
1
Long-Term Investments
241
286
0
0
0
0
0
0
0
0
Other Long-Term Assets
18
17
38
35
80
72
70
60
60
52
Total Assets
1 221
N/A
2 338
+91%
2 566
+10%
2 190
-15%
1 770
-19%
5 377
+204%
4 835
-10%
5 433
+12%
4 266
-21%
4 350
+2%
Liabilities
Accounts Payable
4
15
3
3
0
3
2
2
2
1
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
39
65
170
182
233
299
190
239
152
127
Other Current Liabilities
152
155
98
157
167
753
536
533
282
248
Total Current Liabilities
196
236
271
342
400
1 055
727
775
436
376
Long-Term Debt
122
148
527
442
454
430
240
300
148
56
Deferred Income Tax
48
57
0
0
0
0
0
0
0
0
Other Liabilities
26
26
28
28
29
38
44
42
40
40
Total Liabilities
391
N/A
467
+19%
827
+77%
812
-2%
883
+9%
1 523
+73%
1 011
-34%
1 117
+10%
625
-44%
472
-24%
Equity
Common Stock
2 627
2 907
3 043
3 226
3 592
4 657
559
1 057
1 382
2 076
Retained Earnings
3 327
2 872
3 165
3 892
5 110
4 278
1 035
1 563
2 905
4 075
Additional Paid In Capital
1 445
1 719
1 861
2 045
2 410
3 475
4 310
4 808
5 133
5 828
Unrealized Security Profit/Loss
80
114
0
0
1
0
0
1
2
3
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
5
2
0
1
3
0
10
14
34
52
Total Equity
830
N/A
1 871
+125%
1 739
-7%
1 378
-21%
887
-36%
3 854
+334%
3 824
-1%
4 316
+13%
3 642
-16%
3 878
+6%
Total Liabilities & Equity
1 221
N/A
2 338
+91%
2 566
+10%
2 190
-15%
1 770
-19%
5 377
+204%
4 835
-10%
5 433
+12%
4 266
-21%
4 350
+2%
Shares Outstanding
Common Shares Outstanding
8
9
9
10
10
12
12
13
14
17

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.